Minority-Based Community Clinical Oncology Program Groups
Page 2

The MBCCOP Groups will work by providing patients with access to clinical trials in cancer centers, major university centers, and community programs. And in this manner, this access will be realized through another, separately funded, arm of the program called "Research Bases," which are comprised of participating NCI Cooperative Groups and Cancer Centers.

As a result, the linkages that will soon be developed as a result of this access is expected to facilitate the transfer of advances in cancer prevention/control/treatment practices to minority communities and their physicians.

The National Institutes of Health is ready to administer funds in the amount of $5,500,000 to support the Minority-Based Community Clinical Oncology Program Groups.

The institutions and organizations who will be deemed eligible to submit an application under this program are the following:

a) Public and State Controlled Institutions of Higher Education

b) Native American Tribal Governments

c) Federally recognized Native American Tribal Organizations

d) Nonprofit Organizations

e) Private Institutions of Higher Education

f) For-profit organizations

g) Small businesses

The United States Department of Health and Human Services, the mother agency funding the program, is the nation's premiere agency for protecting the health of all Americans and providing essential human services to everyone, especially to those who are medically challenged and financially vulnerable.

Minority-Based Community Clinical Oncology Program Groups
  Back to Page 1

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

National Institutes of Health: Expanding the Encyclopedia of DNA Elements in Human and Model Organisms
The National Institutes of Health, in cooperation with the National Human Genome Research Institute, has established a funding opportunity to support the Expanding the Encyclopedia of DNA Elements in Human and Model Organisms project.

---

Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---